Health Catalyst (NASDAQ:HCAT) Cut to Inline at Evercore ISI
Evercore ISI cut shares of Health Catalyst (NASDAQ:HCAT – Free Report) from an outperform rating to an inline rating in a research report report published on Wednesday,Briefing.com Automated Import reports. A number of other brokerages also recently issued reports on HCAT. Citigroup lowered their price target on Health Catalyst from $10.50 to $10.00 and set […]
Evercore ISI cut shares of Health Catalyst (NASDAQ:HCAT – Free Report) from an outperform rating to an inline rating in a research report report published on Wednesday,Briefing.com Automated Import reports. A number of other brokerages also recently issued reports on HCAT. Citigroup lowered their price target on Health Catalyst from $10.50 to $10.00 and set […]